Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Z21
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,320
Award facts
- Contract value 100% obligated
- $16,320.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,320.08 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price, non-set-aside contract is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
Cencora, Inc., operating as AmerisourceBergen, is a major pharmaceutical distributor serving federal government agencies with a focus on military and veteran healthcare systems. The parent organization and its subsidiaries supply an extensive portfolio of pharmaceutical products across multiple therapeutic domains through competitively awarded contracts. The DLA Troop Support Medical IDC encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, enabling the company to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order for Dupixent, a biologic treatment for atopic dermatitis and related conditions, represents a routine fulfillment under the broader pharmaceutical supply vehicle supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9Z21?
SPE2DR26F9Z21 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9Z21 worth?
The government has obligated $16,320 on SPE2DR26F9Z21.
Is contract SPE2DR26F9Z21 an order under another contract?
Yes. SPE2DR26F9Z21 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Z21 competed?
The extent of competition for SPE2DR26F9Z21 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award